Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRANEWARE PLC Delisting Announcement 2018

Mar 14, 2018

7581_rns_2018-03-14_189ac9e7-df7c-4da8-bf6f-87c2c738ffa2.html

Delisting Announcement

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7403H

Craneware plc

14 March 2018

Craneware plc

("Craneware", "the Group" or the "Company")

Blocklisting Application

14 March 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market announces that an application (the "Application") has been made to the London Stock Exchange for 200,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission"). All these Ordinary Shares are being reserved under an extension to an existing block listing and will be issued as required in order to satisfy the exercise of share options pursuant to the 2007 Share Option Plan.

It is expected that Admission of these Ordinary Shares will become effective on 16 March 2018. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.

For further information, please contact:

Craneware plc Peel Hunt Alma
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)208 004 4218
Keith Neilson, CEO Dan Webster Caroline Forde
Craig Preston, CFO George Sellar Hilary Buchanan
Nicole McDougall Robyn Fisher

About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

Learn more at www.craneware.com and thevaluecycle.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ALSJIMITMBBBBMP